Stockreport

AnaptysBio's lead candidate shows positive effect in mid-stage peanut allergy study; shares ahead 7% after hours [Seeking Alpha]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF AnaptysBio's lead candidate shows positive effect in mid-stage peanut allergy study; shares ahead 7% after hoursAnaptysBio (NASDAQ:ANAB) is up7% after hours on the heels [Read more]